Biogen Idec Inc (NASDAQ:BIIB)

335.45
Data as of Jul 25
 -1.34 / -0.40%
Today’s Change
203.55
Today|||52-Week Range
358.89
+19.99%
Year-to-Date
Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales - Analyst Blog
Jul 25 / Zacks.com
Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines - Analyst Blog
Jul 23 / Zacks.com
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity...
Jul 25 / Zacks.com
5 Novartis Drugs You Need To Know About
Jul 23 / MotleyFool.com
AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog
Jul 25 / Zacks.com
Why Biogen Idec Inc. Stock Popped Today
Jul 23 / MotleyFool.com
Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session - Tale of the Tape
Jul 25 / Zacks.com
Two Giants Blindsided by Major Trends
Jul 23 / TheStreet.com
Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape
Jul 25 / Zacks.com
Healthcare Spending Uptrend: 3 Medical Stocks for Strong Growth - Analyst Blog
Jul 23 / Zacks.com
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape
Jul 25 / Zacks.com
Morning Market Movers
Jul 23 / Benzinga
UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
Jul 24 / Zacks.com
UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, Shares Surge
Jul 23 / Benzinga
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
Jul 24 / Zacks.com
That was fast. New record for stock market
Jul 23 / CNNMoney.com
Actelion Beats on Q2 Earnings and Sales, Revises View - Analyst Blog
Jul 24 / Zacks.com
Benzinga's Top #PreMarket Gainers
Jul 23 / Benzinga
Why Biogen Idec Stock Is Firing on All Cylinders
Jul 24 / MotleyFool.com
Biogen Idec Stock Spikes Following Second Quarter Earnings Beat
Jul 23 / TheStreet.com
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog
Jul 24 / Zacks.com
Biogen Idec (BIIB) Leading In Pre-Market Activity
Jul 23 / TheStreet.com
Stock Market News for July 24, 2014 - Market News
Jul 24 / Zacks.com
Wednesdaybs Top Health Care Stories: Puma, Biogen, and Intuitive Surgical
Jul 23 / MotleyFool.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
Jul 24 / Zacks.com
Earnings Scheduled For July 23, 2014
Jul 23 / Benzinga
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Jul 24 / Zacks.com
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Jul 22 / MotleyFool.com
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y - Analyst Blog
Jul 24 / Zacks.com
Trading Radar for 07/23: Facebook (FB), Pepsi (PEP), AT&T (T), Dow (DOW), Qualcomm (Q...
Jul 22 / Investing Channel
Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape
Jul 24 / Zacks.com
3 Stocks Reiterated As A Buy: CAT, BIIB, AMGN
Jul 22 / TheStreet.com
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session - Tale of the Tape
Jul 24 / Zacks.com
Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? - Analyst Blog
Jul 22 / Zacks.com
Time to Focus on Biogen Idec (BIIB) for Strong Earnings Growth Potential - Tale of ...
Jul 24 / Zacks.com
Is a Surprise Coming for Biogen Idec (BIIB) This Earnings Season? - Tale of the Tape
Jul 22 / Zacks.com
Cramer: Every Which Way But Short
Jul 24 / TheStreet.com
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog
Jul 21 / Zacks.com
Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG
Jul 24 / TheStreet.com
Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
Jul 21 / Zacks.com
Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog
Jul 23 / Zacks.com
Yellen Hates Biotech Stocks! Should You?
Jul 21 / MotleyFool.com
3 Key Takeaways from Biogen Idec Inc Stock's Earnings Annihilation
Jul 23 / MotleyFool.com
Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog
Jul 21 / Zacks.com
Vertex Is Poised For An Earnings Breakout
Jul 23 / Benzinga
Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher - Tale of the Tape
Jul 21 / Zacks.com
Biogen Stock's Tecfidera Embarrasses Wall Street
Jul 23 / MotleyFool.com
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
Jul 21 / Zacks.com
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst...
Jul 23 / Zacks.com
Why the Market is Wrong About Baxter Stock
Jul 18 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.